LEADER 00853nam0-22002651i-450 001 990005342360403321 005 20230321114754.0 035 $a000534236 035 $aFED01000534236 035 $a(Aleph)000534236FED01 035 $a000534236 100 $a19990530d1960----km-y0itay50------ba 101 0 $aita 105 $aa-------00--- 200 1 $a<>nuovi metodi di prospezione archeologica alla scoperta delle civilta sepolte$fCarlo Maurilio Lerici 210 $aMilano$cLerici Editori$dc.1960 215 $a418 p.$cill.$d24 cm 700 1$aLerici,$bCarlo Maurilio$0207035 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990005342360403321 952 $aARCH. OA 018 8$bARCH.9916$fFLFBC 959 $aFLFBC 996 $aNuovi metodi di prospezione archeologica alla scoperta delle civiltà sepolte$9283586 997 $aUNINA LEADER 05638nam 22005055 450 001 9910349265903321 005 20251116161307.0 010 $a94-007-7742-6 024 7 $a10.1007/978-94-007-7742-2 035 $a(CKB)3710000000838523 035 $a(DE-He213)978-94-007-7742-2 035 $a(PPN)242975739 035 $a(EXLCZ)993710000000838523 100 $a20190617d2020 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBiomarkers in Liver Disease /$fedited by Vinood B. Patel, Victor R. Preedy 210 1$aDordrecht :$cSpringer Netherlands :$cImprint: Springer,$d2020. 215 $a1 online resource (800 p. 50 illus.) 225 1 $aBiomarkers in Disease: Methods, Discoveries and Applications,$x2542-3657 327 $aLiver biomarkers and their applications to nutritional interventions in animal studies -- AST-to-platelet ratio index (APRI) as marker in liver disease.-Inflammatory biomarkers in ascites -- Biomarkers for hepatocellular carcinoma in East Asia -- Liver disease and acylcarnitines as mechanistic biomarkers.-Type VI Collagen: Biological Functions and its Neo-epitope as Hepatic Fibrosis Biomarker -- Fibrinogen ?-chain as a serum marker of liver disease -- Monocyte chemotactic protein-1 (cytokine, receptors,and gene polymorphisms) in hepatitis -- Biomarkers for Recurrence of Hepatocellular Carcinoma.-Graft-derived cell-free DNA as a biomarker in liver transplantation -- Serum sialic acid as a biomarker in liver disease -- CD133 and EpCAM as Biomarkers in Liver Diseases -- Traditional markers in liver disease -- Biomarkers of extracellular matrix remodeling in liver diseases -- Squamous Cell Carcinoma Antigen- Immunoglobulin M (SCCA-IgM) as biomarker in liver disease: biological aspects and clinical applications -- microRNA-155 and microRNA-196b in hepatitis C virus infection -- Immunological biomarkers in liver transplantation -- Phosphatidylethanol and alcohol use in liver disease patients -- Interaction of sialyltransferases, sialidases and sialic acids in liver diseases and applications to biomarker discovery -- Biomarkers to monitor graft function following liver transplantation -- YKL-40 as a biomarker of liver diseases -- Peripheral venous, portal venous, hepatic venous, arterial and intrahepatic cytokine levels as biomarkers and functional correlations -- Histological Biomarkers of Non-Alcoholic Fatty Liver Disease -- Vascular cell adhesion molecule-1 (vcam-1) expression in liver disease -- Bilirubin as a biomarker in liver disease -- Hydroxyproline as a biomarker in liver disease -- Genetic biomarkers of paracetamol-induced acute liver failure -- PNPLA3 polymorphism and Nonalcoholic Fatty Liver Disease -- Hepascore and it's application to liver disease -- Model for End-Stage Liver Disease (MELD) Score as a Biomarker -- Biomarkers in focus: Alanine Aminotransferase -- PTX3 as a biomarker of liver disease. 330 $aIn the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists. 410 0$aBiomarkers in Disease: Methods, Discoveries and Applications,$x2542-3657 606 $aCancer$xResearch 606 $aOncology 606 $aPharmacology 606 $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007 615 0$aCancer$xResearch. 615 0$aOncology. 615 0$aPharmacology. 615 14$aCancer Research. 615 24$aOncology. 615 24$aPharmacology/Toxicology. 676 $a614.5999 702 $aPatel$b Vinood B.$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aPreedy$b Victor R.$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910349265903321 996 $aBiomarkers in Liver Disease$91984562 997 $aUNINA